Replies to post #89570 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

I'm just saying that if they (CTIX and FDA) wanted to, they could have defined the trial differently and been able to have saved some time.

Phase 1:
Primary endpoint = Converts/safety
Secondary endpoint = Cures Psoriasis

The trial might have taken longer but we would have been farther along and could start a Phase 3 right away.

Plus our market cap would have been through the roof if the results were the same as in mice.